Taxotere News - Permanent Hair Loss

Below are some of our news stories explaining the potential dangers of the chemotherapy drug Taxotere, and especially the connection to permanent hair loss. To learn more about the types of injuries that have been linked to this medication, and the legal claims that have been filed, click Taxotere.

 
  • The Psychological Impacts of Taxotere Hair Loss

    One of the challenges when it comes to determining damages in injury lawsuits is putting a monetary value on intangible losses, such as pain and suffering, emotional distress, and anxiety. These are considered to be “non-economic damages,” and fall under the category of “mental anguish.” Putting a dollar figure on emotional pain is difficult, but it is nonetheless a factor that can diminish the quality of life as surely as a crippling injury.

    read more
  • Generic Taxotere Is Now Being Targeted in Hair Loss Litigation

    In a development that is highly unusual in drug litigation, eight pharmaceutical companies involved in the manufacture and marketing of generic Taxotere (docetaxel) are now being named as defendants in current multi-district litigation moving forward in a Louisiana federal court. So far, 1,000 women who have suffered hair loss from Taxotere treatments have filed suit against French drugmaker Sanofi-Aventis.

    read more
  • Drugmaker Sanofi-Aventis Kept Doctors in the Dark About Taxotere Hair Loss – But They're Blaming the FDA

    “Carla” (not her real name) is grateful to be a breast cancer survivor. She knew that the chemotherapy treatments would cause her hair to fall out – but she never thought that hair loss would be permanent.

    Even though she has been cancer-free for six years, she says, “People look [at me] and they have a sympathy look...I look like I have cancer.” It wasn't until she saw a social media post that she understood why her hair never grew back after her course of treatment was over. That post named Taxotere, the drug her oncologist used to treat her condition.

    read more
  • Taxotere -- The Permanent Hair Loss Side Effect

    Taxotere (docetaxel) is a chemotherapy drug that is part of the class known as taxanes. This class also includes Taxol (paclitaxel). Both drugs are mitotic inhibitors, meaning that they interfere with the process of mitosis, or cell division.  Although these drugs are intended to target malignant cancer cells, they do affect the reproduction of other cells as well – including hair follicles. This is the reason that cancer patients undergoing chemotherapy suffer hair loss.

    read more